| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +4.29% | +1.86% | +2.43% | +2.43% | — |
| 14d | 1 | +0.00% | +5.15% | +2.59% | +2.56% | +2.56% | — |
| 30d | 1 | +0.00% | +17.02% | +3.58% | +13.43% | +13.43% | — |
| 60d | 1 | +0.00% | +22.24% | +8.14% | +14.09% | +14.09% | — |
| 90d | 1 | +0.00% | +30.63% | +10.77% | +19.86% | +19.86% | — |
| 180d | 1 | +100.00% | -10.70% | +18.94% | -29.64% | -29.64% | — |
| 1y | 1 | +100.00% | -0.30% | +32.80% | -33.10% | -33.10% | — |
| 2y | 1 | +100.00% | -76.50% | +14.77% | -91.27% | -91.27% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| NEO NEOGENOMICS INC | PURCHASEGRANT Stock grant | 24,619 | $53.17 | $1.31M | 24,619 | Mar 2, 2021 | Mar 3, 2021 ↗ |
| NEO NEOGENOMICS INC | PURCHASEGRANT Stock grant | 4,345 | — | — | 60,643 | Mar 2, 2021 | Mar 3, 2021 ↗ |
| NEO NEOGENOMICS INC | SALE General Counsel | 216 | — | — | 56,298 | Mar 2, 2021 | Mar 3, 2021 ↗ |
| NEO NEOGENOMICS INC | SALE General Counsel | 212 | — | — | 56,514 | Mar 1, 2021 | Mar 3, 2021 ↗ |
| NEO NEOGENOMICS INC | SALE General Counsel | 2,262 | $42.00 | $95.0K | 56,726 | Nov 10, 2020 | Nov 12, 2020 ↗ |
| NEO NEOGENOMICS INC | SALE General Counsel | 15,000 | — | — | 0 | Nov 10, 2020 | Nov 12, 2020 ↗ |
| NEO NEOGENOMICS INC | PURCHASE General Counsel | 15,000 | $7.85 | $117.8K | 58,988 | Nov 10, 2020 | Nov 12, 2020 ↗ |
| NEO NEOGENOMICS INC | PURCHASEGRANT Stock grant | 2,912 | — | — | 43,988 | Mar 2, 2020 | Mar 3, 2020 ↗ |
| NEO NEOGENOMICS INC | PURCHASEGRANT Stock grant | 18,757 | $28.33 | $531.4K | 18,757 | Mar 2, 2020 | Mar 3, 2020 ↗ |